Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis

NCT04133194 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: Mesalazine
DRUG: Mesalazine

Sponsor

Flemming Bendtsen